Conduit Pharmaceuticals Inc. (CDT) — Cash Flow Quality Index

Latest as of June 2026: 0.62x

Conduit Pharmaceuticals Inc. (CDT) has a Cash Flow Quality Index of 0.62x as of June 2026. Operating cash flow of $42.74 Million is below net income of $68.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Conduit Pharmaceuticals Inc. to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.62x

Operating CF / Net Income

Operating Cash Flow

$42.74 Million

USD

Net Income

$68.54 Million

USD

Data as of

Jun 2026

Most recent filing

Annual Cash Flow Quality Index for Conduit Pharmaceuticals Inc. (None–None)

Year-by-year earnings quality comparison for Conduit Pharmaceuticals Inc..

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.